Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists

Patients with type 2 diabetes vary in their response to currently available therapeutic agents (including GLP-1 receptor agonists) leading to suboptimal glycemic control and increased risk of complications. We show that human carriers of hypomorphic T2D-risk alleles in the gene encoding peptidyl-gly...

Descripción completa

Detalles Bibliográficos
Autores principales: Umapathysivam, Mahesh M, Araldi, Elisa, Hastoy, Benoit, Dawed, Adem Y, Vatandaslar, Hasan, Sengupta, Shahana, Kaufmann, Adrian, Thomsen, Søren, Hartmann, Bolette, Jonsson, Anna E, Kabakci, Hasan, Thaman, Swaraj, Grarup, Niels, Have, Christian T, Færch, Kristine, Gjesing, Anette P, Nawaz, Sameena, Cheeseman, Jane, Neville, Matthew J, Pedersen, Oluf, Walker, Mark, Jennison, Christopher, Hattersley, Andrew T, Hansen, Torben, Karpe, Fredrik, Holst, Jens J, Jones, Angus G, Ristow, Michael, McCarthy, Mark I, Pearson, Ewan R, Stoffel, Markus, Gloyn, Anna L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120798/
https://www.ncbi.nlm.nih.gov/pubmed/37090505
http://dx.doi.org/10.1101/2023.04.07.23288197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120798/
https://www.ncbi.nlm.nih.gov/pubmed/37090505
http://dx.doi.org/10.1101/2023.04.07.23288197

Ejemplares similares